News, archive: December 2020
12/25/2020 Analysis of Intersections Occurring when Pharmacies Cooperate with More than One Pharmacy Association (Q1 – Q3 2020)
While working with pharmacy associations, manufacturing companies and therefore, customers of marketing activities will inevitably have to face the following issue: some pharmacies cooperate with more than one association, which leads to the duplication of sales in the accounting reports. That, in turn, leads to the problem of fair settlements with associations, which could then result in incorrect planning and accounting distortion between different departments, as well as bring complications when assigning tasks to medical representatives, etc.
Between January and November 2020, Russia produced RUB 450.7 bln worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 17.4% higher than in 2019. The production volume in physical terms (units) amounts to 4.4 bln units, with the growth rate of +6.5%. If calculated in minimum dosage units (MDU), the growth rate is higher (+10.7%) and the production volume is 74.6 bln MDUs.
12/10/2020 API Import to Russia (October 2020)
Between January and October 2020, Russia imported RUB 134.1 bln worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 20% higher than in 2019. The import volume in physical terms (tons) amounted to 12.1 thousand tons, with the growth rate of +12%.
Between January and October 2020, Russia imported RUB 404 bln worth of ready-made pharmaceutical drugs (customs clearance and VAT included), which is in monetary terms (rubles) 29.6% lower than in 2019. That is clearly the high base effect, since back in October 2019 the importers were hard at work, preparing for the launch of the labeling system by actively stocking up the warehouses; the import volumes were 2-3 times higher than usual. The growth rates of the in-bulk import are still positive, although only +2.2%, with the import volume of RUB 110.8 bln.
Between January and September 2020, Russia exported RUB 40.2 bln worth of ready-made pharmaceutical drugs (customs duties included), which is virtually comparable of the total export volume in 2018. The dynamics in monetary terms (rubles) are as high as +23.3%. The export volume in physical terms amounts to 0.83 bln units, with the dynamics of +27.5%.